Risk factors for self-reported visual symptoms with Intacs inserts for myopia

Debby K. Holmes-Higgin, Terry E. Burris, Jodi Lapidus, Merwyn R. Greenlick

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Objective: Potential risk factors and visual performance measures were evaluated for relationship to self-report of clinical visual symptoms after the refractive procedure for placement of Intacs microthin prescription inserts for myopia. Design: Retrospective nonrandomized comparative study. Participants/Intervention: Patients were participants in the U.S. Food and Drug Administration phase III KeraVision prospective clinical trials. Main Outcome Measures: Study participants (n = 263) were retrospectively classified into one of three outcome groups on the basis of postoperative self-reported visual symptoms and/or request for Intacs inserts removal through month 24. Differences between outcome groups in visual acuity, refractive error, corneal geometry, corneal topography, type of preoperative corrective lens wear, and demographic variables were evaluated with multivariate logistic regression. Results: Clinical trial participants who had preoperative mean keratometry >45 diopters (D) (adjusted odds ratio [OR], 0.43; 95% confidence interval [Cl], 0.21, 0.85, P = 0.02), manifest refractive astigmatism of 0.75 D or 1.00 D (adjusted OR, 0.52; 95% Cl, 0.25, 1.08, P = 0.08), measured uncorrected visual acuity ≥2 lines better than that predicted by their respective cycloplegic refractive error (adjusted OR, 0.39; 95% Cl, 0.14, 1.12, P = 0.08) and/or had worn soft contact lenses (adjusted OR, 0.58; 95% Cl, 0.32, 1.04, P = 0.07) tended to be less likely to report postoperative clinical visual symptoms with Intacs inserts. Risk of clinical visual symptoms and request for Intacs inserts removal approximately doubled for each 0.50 D of additional postoperative defocus equivalent (crude OR, 1.86; 95% Cl, 1.39, 2.48, P = 0.00). Controlling for postoperative defocus and important preoperative risk factors, subjects who reported significant clinical visual symptoms were more likely to have had preoperative uncorrected visual acuity that was worse than that predicted by their respective cycloplegic refractive error (adjusted OR, 1.84; 95% Cl, 0.98, 3.42, P = 0.06). Risk of reporting clinical visual symptoms was increased with mesopic pupil diameter ≥6.5 mm (adjusted OR, 1.76; 95% Cl, 0.96, 3.24, P = 0.07). Within the group of patients who reported postoperative clinical visual symptoms, 71 of 122 (58%) had ceased reporting them by month 24. Conclusions: Adjusting for important risk factors simultaneously, this study suggested that certain preoperative characteristics may increase or decrease the likelihood, depending on the characteristic, of refractive surgery candidates to report significant clinical visual symptoms with Intacs inserts.

Original languageEnglish (US)
Pages (from-to)46-56
Number of pages11
JournalOphthalmology
Volume109
Issue number1
DOIs
StatePublished - 2002

Fingerprint

Myopia
Odds Ratio
Refractive Errors
Visual Acuity
Mydriatics
Outcome Assessment (Health Care)
Clinical Trials
Corneal Topography
Hydrophilic Contact Lens
Refractive Surgical Procedures
Astigmatism
United States Food and Drug Administration
Pupil
Self Report
Lenses
Prescriptions
Logistic Models
Demography
Confidence Intervals

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Risk factors for self-reported visual symptoms with Intacs inserts for myopia. / Holmes-Higgin, Debby K.; Burris, Terry E.; Lapidus, Jodi; Greenlick, Merwyn R.

In: Ophthalmology, Vol. 109, No. 1, 2002, p. 46-56.

Research output: Contribution to journalArticle

Holmes-Higgin, Debby K. ; Burris, Terry E. ; Lapidus, Jodi ; Greenlick, Merwyn R. / Risk factors for self-reported visual symptoms with Intacs inserts for myopia. In: Ophthalmology. 2002 ; Vol. 109, No. 1. pp. 46-56.
@article{697f5788a0dd4db5ab6c59b1ca775edc,
title = "Risk factors for self-reported visual symptoms with Intacs inserts for myopia",
abstract = "Objective: Potential risk factors and visual performance measures were evaluated for relationship to self-report of clinical visual symptoms after the refractive procedure for placement of Intacs microthin prescription inserts for myopia. Design: Retrospective nonrandomized comparative study. Participants/Intervention: Patients were participants in the U.S. Food and Drug Administration phase III KeraVision prospective clinical trials. Main Outcome Measures: Study participants (n = 263) were retrospectively classified into one of three outcome groups on the basis of postoperative self-reported visual symptoms and/or request for Intacs inserts removal through month 24. Differences between outcome groups in visual acuity, refractive error, corneal geometry, corneal topography, type of preoperative corrective lens wear, and demographic variables were evaluated with multivariate logistic regression. Results: Clinical trial participants who had preoperative mean keratometry >45 diopters (D) (adjusted odds ratio [OR], 0.43; 95{\%} confidence interval [Cl], 0.21, 0.85, P = 0.02), manifest refractive astigmatism of 0.75 D or 1.00 D (adjusted OR, 0.52; 95{\%} Cl, 0.25, 1.08, P = 0.08), measured uncorrected visual acuity ≥2 lines better than that predicted by their respective cycloplegic refractive error (adjusted OR, 0.39; 95{\%} Cl, 0.14, 1.12, P = 0.08) and/or had worn soft contact lenses (adjusted OR, 0.58; 95{\%} Cl, 0.32, 1.04, P = 0.07) tended to be less likely to report postoperative clinical visual symptoms with Intacs inserts. Risk of clinical visual symptoms and request for Intacs inserts removal approximately doubled for each 0.50 D of additional postoperative defocus equivalent (crude OR, 1.86; 95{\%} Cl, 1.39, 2.48, P = 0.00). Controlling for postoperative defocus and important preoperative risk factors, subjects who reported significant clinical visual symptoms were more likely to have had preoperative uncorrected visual acuity that was worse than that predicted by their respective cycloplegic refractive error (adjusted OR, 1.84; 95{\%} Cl, 0.98, 3.42, P = 0.06). Risk of reporting clinical visual symptoms was increased with mesopic pupil diameter ≥6.5 mm (adjusted OR, 1.76; 95{\%} Cl, 0.96, 3.24, P = 0.07). Within the group of patients who reported postoperative clinical visual symptoms, 71 of 122 (58{\%}) had ceased reporting them by month 24. Conclusions: Adjusting for important risk factors simultaneously, this study suggested that certain preoperative characteristics may increase or decrease the likelihood, depending on the characteristic, of refractive surgery candidates to report significant clinical visual symptoms with Intacs inserts.",
author = "Holmes-Higgin, {Debby K.} and Burris, {Terry E.} and Jodi Lapidus and Greenlick, {Merwyn R.}",
year = "2002",
doi = "10.1016/S0161-6420(01)00858-2",
language = "English (US)",
volume = "109",
pages = "46--56",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Risk factors for self-reported visual symptoms with Intacs inserts for myopia

AU - Holmes-Higgin, Debby K.

AU - Burris, Terry E.

AU - Lapidus, Jodi

AU - Greenlick, Merwyn R.

PY - 2002

Y1 - 2002

N2 - Objective: Potential risk factors and visual performance measures were evaluated for relationship to self-report of clinical visual symptoms after the refractive procedure for placement of Intacs microthin prescription inserts for myopia. Design: Retrospective nonrandomized comparative study. Participants/Intervention: Patients were participants in the U.S. Food and Drug Administration phase III KeraVision prospective clinical trials. Main Outcome Measures: Study participants (n = 263) were retrospectively classified into one of three outcome groups on the basis of postoperative self-reported visual symptoms and/or request for Intacs inserts removal through month 24. Differences between outcome groups in visual acuity, refractive error, corneal geometry, corneal topography, type of preoperative corrective lens wear, and demographic variables were evaluated with multivariate logistic regression. Results: Clinical trial participants who had preoperative mean keratometry >45 diopters (D) (adjusted odds ratio [OR], 0.43; 95% confidence interval [Cl], 0.21, 0.85, P = 0.02), manifest refractive astigmatism of 0.75 D or 1.00 D (adjusted OR, 0.52; 95% Cl, 0.25, 1.08, P = 0.08), measured uncorrected visual acuity ≥2 lines better than that predicted by their respective cycloplegic refractive error (adjusted OR, 0.39; 95% Cl, 0.14, 1.12, P = 0.08) and/or had worn soft contact lenses (adjusted OR, 0.58; 95% Cl, 0.32, 1.04, P = 0.07) tended to be less likely to report postoperative clinical visual symptoms with Intacs inserts. Risk of clinical visual symptoms and request for Intacs inserts removal approximately doubled for each 0.50 D of additional postoperative defocus equivalent (crude OR, 1.86; 95% Cl, 1.39, 2.48, P = 0.00). Controlling for postoperative defocus and important preoperative risk factors, subjects who reported significant clinical visual symptoms were more likely to have had preoperative uncorrected visual acuity that was worse than that predicted by their respective cycloplegic refractive error (adjusted OR, 1.84; 95% Cl, 0.98, 3.42, P = 0.06). Risk of reporting clinical visual symptoms was increased with mesopic pupil diameter ≥6.5 mm (adjusted OR, 1.76; 95% Cl, 0.96, 3.24, P = 0.07). Within the group of patients who reported postoperative clinical visual symptoms, 71 of 122 (58%) had ceased reporting them by month 24. Conclusions: Adjusting for important risk factors simultaneously, this study suggested that certain preoperative characteristics may increase or decrease the likelihood, depending on the characteristic, of refractive surgery candidates to report significant clinical visual symptoms with Intacs inserts.

AB - Objective: Potential risk factors and visual performance measures were evaluated for relationship to self-report of clinical visual symptoms after the refractive procedure for placement of Intacs microthin prescription inserts for myopia. Design: Retrospective nonrandomized comparative study. Participants/Intervention: Patients were participants in the U.S. Food and Drug Administration phase III KeraVision prospective clinical trials. Main Outcome Measures: Study participants (n = 263) were retrospectively classified into one of three outcome groups on the basis of postoperative self-reported visual symptoms and/or request for Intacs inserts removal through month 24. Differences between outcome groups in visual acuity, refractive error, corneal geometry, corneal topography, type of preoperative corrective lens wear, and demographic variables were evaluated with multivariate logistic regression. Results: Clinical trial participants who had preoperative mean keratometry >45 diopters (D) (adjusted odds ratio [OR], 0.43; 95% confidence interval [Cl], 0.21, 0.85, P = 0.02), manifest refractive astigmatism of 0.75 D or 1.00 D (adjusted OR, 0.52; 95% Cl, 0.25, 1.08, P = 0.08), measured uncorrected visual acuity ≥2 lines better than that predicted by their respective cycloplegic refractive error (adjusted OR, 0.39; 95% Cl, 0.14, 1.12, P = 0.08) and/or had worn soft contact lenses (adjusted OR, 0.58; 95% Cl, 0.32, 1.04, P = 0.07) tended to be less likely to report postoperative clinical visual symptoms with Intacs inserts. Risk of clinical visual symptoms and request for Intacs inserts removal approximately doubled for each 0.50 D of additional postoperative defocus equivalent (crude OR, 1.86; 95% Cl, 1.39, 2.48, P = 0.00). Controlling for postoperative defocus and important preoperative risk factors, subjects who reported significant clinical visual symptoms were more likely to have had preoperative uncorrected visual acuity that was worse than that predicted by their respective cycloplegic refractive error (adjusted OR, 1.84; 95% Cl, 0.98, 3.42, P = 0.06). Risk of reporting clinical visual symptoms was increased with mesopic pupil diameter ≥6.5 mm (adjusted OR, 1.76; 95% Cl, 0.96, 3.24, P = 0.07). Within the group of patients who reported postoperative clinical visual symptoms, 71 of 122 (58%) had ceased reporting them by month 24. Conclusions: Adjusting for important risk factors simultaneously, this study suggested that certain preoperative characteristics may increase or decrease the likelihood, depending on the characteristic, of refractive surgery candidates to report significant clinical visual symptoms with Intacs inserts.

UR - http://www.scopus.com/inward/record.url?scp=0036135606&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036135606&partnerID=8YFLogxK

U2 - 10.1016/S0161-6420(01)00858-2

DO - 10.1016/S0161-6420(01)00858-2

M3 - Article

C2 - 11772579

AN - SCOPUS:0036135606

VL - 109

SP - 46

EP - 56

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 1

ER -